New Zealand markets close in 5 hours 25 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
496.07+0.91 (+0.18%)
At close: 04:03PM EDT
496.07 0.00 (0.00%)
After hours: 06:48PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 14.58B
Enterprise value 13.91B
Trailing P/E N/A
Forward P/E 39.53
PEG ratio (5-yr expected) 4.34
Price/sales (ttm)5.15
Price/book (mrq)1.44
Enterprise value/revenue 4.80
Enterprise value/EBITDA -151.58

Trading information

Stock price history

Beta (5Y monthly) 0.92
52-week change 3-23.15%
S&P500 52-week change 3-11.08%
52-week high 3832.70
52-week low 3462.61
50-day moving average 3511.05
200-day moving average 3637.48

Share statistics

Avg vol (3-month) 3219.67k
Avg vol (10-day) 3181.64k
Shares outstanding 524.62M
Implied shares outstanding 6N/A
Float 821.48M
% held by insiders 114.31%
% held by institutions 179.43%
Shares short (30 May 2022) 4563.32k
Short ratio (30 May 2022) 42.28
Short % of float (30 May 2022) 42.67%
Short % of shares outstanding (30 May 2022) 41.90%
Shares short (prior month 28 Apr 2022) 4332.76k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 307 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -3.49%
Operating margin (ttm)20.63%

Management effectiveness

Return on assets (ttm)2.64%
Return on equity (ttm)-0.97%

Income statement

Revenue (ttm)2.9B
Revenue per share (ttm)96.98
Quarterly revenue growth (yoy)-3.70%
Gross profit (ttm)1.67B
EBITDA 730.39M
Net income avi to common (ttm)-101.12M
Diluted EPS (ttm)-3.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.07B
Total cash per share (mrq)69.25
Total debt (mrq)1.4B
Total debt/equity (mrq)13.78
Current ratio (mrq)5.09
Book value per share (mrq)340.10

Cash flow statement

Operating cash flow (ttm)589.23M
Levered free cash flow (ttm)433.23M